I now have comprehensive information from authoritative textbook sources (Fitzpatrick's Dermatology, Katzung Pharmacology, Andrews' Diseases of the Skin, Goodman & Gilman) plus verified drug database sources. Here is the full description:
Ketoconazole + Iodochlorhydroxyquinoline + Tolnaftate + Gentamicin + Clobetasol Propionate Cream
Full Description
This is a broad-spectrum, penta-combination topical cream that simultaneously targets bacterial infection, fungal infection, and skin inflammation. It is widely marketed in India under brand names such as Dermicube, Dermiact, Dermipan, Ketohext Plus, Ketonage-Plus, Dermitek, D-Derm KT, K2-Tone, and others.
Composition (Typical Strengths)
| Ingredient | Typical Concentration | Drug Class |
|---|
| Clobetasol Propionate | 0.05% w/w | Super-potent corticosteroid (Class I) |
| Ketoconazole | 2.0% w/w | Azole antifungal |
| Iodochlorhydroxyquinoline (Clioquinol) | 1.0% w/w | Halogenated quinoline antimicrobial |
| Tolnaftate | 1.0% w/w | Thiocarbamate antifungal |
| Gentamicin Sulphate | 0.1% w/w | Aminoglycoside antibiotic |
Pack size: 15 g tube | Route: Topical only | Prescription required (Schedule H)
Mechanism of Action - Each Ingredient
1. Clobetasol Propionate (0.05%) - Super-Potent Corticosteroid
- Binds cytosolic glucocorticoid receptors, translocates to the nucleus
- Suppresses transcription of pro-inflammatory genes (phospholipase A2 inhibition via lipocortin)
- Blocks prostaglandins, leukotrienes, histamine, cytokines - reducing redness, swelling, itching, and skin inflammation
- Class I (super-potent) steroid - the strongest category of topical corticosteroid
- Anti-proliferative action reduces epidermal cell turnover in conditions like psoriasis
- Source: Lippincott Pharmacology; Andrews' Diseases of the Skin
2. Ketoconazole (2%) - Azole Antifungal
- Inhibits fungal cytochrome P450 14α-demethylase enzyme
- Blocks conversion of lanosterol → ergosterol (essential fungal cell membrane sterol)
- Disrupts fungal membrane integrity and permeability, leading to cell death
- Fungicidal at high concentrations; fungistatic at lower levels
- Additional anti-inflammatory activity has been postulated for topical formulations
- Effective against: dermatophytes (Tinea spp.), Candida spp., Malassezia (Pityrosporum)
- Systemic absorption of topical ketoconazole is negligible
- Source: Fitzpatrick's Dermatology, Vol. 1-2
3. Iodochlorhydroxyquinoline / Clioquinol (1%) - Halogenated Quinoline
- Broad-spectrum antimicrobial with both antibacterial and antifungal activity
- Mechanism: chelates metal ions (particularly zinc and iron) essential for microbial enzyme function
- Disrupts cell membrane integrity and inhibits vital enzyme systems in both bacteria and fungi
- Active against gram-positive bacteria, some gram-negative bacteria, and fungi (including Candida)
- Provides an additional layer of coverage against bacteria not covered by gentamicin alone
- Releases iodine and chlorine ions that have direct antimicrobial activity
4. Tolnaftate (1%) - Thiocarbamate Antifungal
- Inhibits squalene epoxidase enzyme in fungi (same enzyme targeted by terbinafine)
- Blocks the conversion of squalene to lanosterol, disrupting ergosterol synthesis
- Leads to accumulation of squalene in the fungal cell, which is toxic
- Effective against dermatophytes: Epidermophyton, Microsporum, Trichophyton spp.
- Also active against Malassezia (Pityriasis versicolor)
- Not effective against Candida - this is why ketoconazole is also included
- Generally well tolerated; rarely causes irritation or allergic contact dermatitis
- Available as cream, powder, solution, aerosol; used twice daily for 2-4 weeks
- Source: Katzung's Basic & Clinical Pharmacology, 16th Edition; Jawetz Microbiology
5. Gentamicin Sulphate (0.1%) - Aminoglycoside Antibiotic
- Binds irreversibly to the 30S ribosomal subunit (specifically 16S rRNA)
- Causes misreading of mRNA codons → incorporates wrong amino acids → faulty proteins
- Also disrupts bacterial cell membrane integrity by direct binding
- Requires oxygen-dependent active transport into bacterial cell (therefore ineffective against strict anaerobes)
- Spectrum: Broad-spectrum gram-negative coverage (Pseudomonas, E. coli, Klebsiella, Proteus) and some gram-positive (Staphylococcus aureus)
- Topical gentamicin is used for infected skin lesions including impetigo and secondarily infected wounds
- Source: Goodman & Gilman; Medical Microbiology
Therapeutic Uses (Indications)
| Condition | Rationale |
|---|
| Tinea corporis (Ringworm) | Ketoconazole + Tolnaftate target dermatophytes; Clobetasol reduces itch/inflammation |
| Tinea cruris (Jock itch) | Dual antifungal coverage; Clobetasol reduces erythema |
| Tinea pedis (Athlete's foot) | Dermatophyte coverage + antibacterial for secondary infection |
| Tinea versicolor | Ketoconazole targets Malassezia species |
| Cutaneous candidiasis | Ketoconazole provides azole coverage for Candida |
| Infected eczema / Atopic dermatitis | Clobetasol controls inflammation; Gentamicin + Clioquinol cover bacterial superinfection |
| Secondarily infected psoriasis | Anti-inflammatory + antimicrobial coverage |
| Intertrigo (Skin fold infections) | Mixed bacterial-fungal infections in warm, moist skin folds |
| Infected contact dermatitis | Addresses both inflammation and secondary infection |
| Seborrheic dermatitis with secondary infection | Ketoconazole targets Malassezia; steroid reduces scaling/inflammation |
| Napkin/diaper dermatitis (secondary infection) | Combined coverage with caution |
Dosage and Administration
- Route: External/Topical use only
- Method: Apply a thin layer to the affected area(s) with clean, dry hands
- Frequency: Usually twice daily (morning and evening), or as directed by the prescriber
- Duration: Typically 2-4 weeks maximum - limit use due to the potent steroid content
- Clean and dry the affected area before application
- Avoid occlusive dressings unless specifically instructed by the doctor
- Wash hands after applying (unless hands are the affected area)
Side Effects
Local / Application Site (Common)
- Burning and stinging at application site
- Erythema (redness) and irritation
- Itching (paradoxical)
- Skin peeling and dryness
Corticosteroid-Related (with Prolonged Use) - Andrews' Diseases of the Skin
- Skin atrophy - thinning, fragility, purpura
- Striae distensae (stretch marks, irreversible)
- Telangiectasia - visible small blood vessels, especially on the face
- Hypopigmentation - skin lightening at application site
- Hypertrichosis - local increased hair growth
- Perioral dermatitis / Steroid rosacea - especially with facial use
- Acneiform eruption - steroid acne
- "Steroid addiction" - severe rebound on stopping, especially on face/genitalia
- Tachyphylaxis - reduced efficacy with continued use
- HPA axis suppression - if used over large areas; risk of Addisonian crisis and Cushing syndrome; growth retardation in children (>50% BSA)
Gentamicin-Related
- Contact sensitization - allergic contact dermatitis
- Ototoxicity (hearing loss) - rare, with extensive topical use on large wounds/burns
- Nephrotoxicity - rare with topical use
Ketoconazole-Related (Topical - Rare)
- Itching, contact dermatitis, allergic reactions
- Minimal systemic absorption from topical use
Clioquinol (Iodochlorhydroxyquinoline)-Related
- Yellow/brown staining of skin, nails, and clothing
- Mild irritation
- May give false-positive PBI (protein-bound iodine) test results due to iodine content
- Rarely, systemic absorption can cause subacute myelo-optic neuropathy (SMON) - only with very extensive/prolonged use
Contraindications
- Known allergy/hypersensitivity to any of the five active ingredients
- Viral skin infections - herpes simplex, varicella zoster, molluscum contagiosum (steroid worsens these)
- Tuberculosis of the skin (lupus vulgaris)
- Rosacea and perioral dermatitis (steroid aggravates)
- Acne vulgaris (steroid acne risk)
- Perianal and genital use without strict specialist supervision - high absorption, atrophy risk
- Ophthalmic use (near or in the eyes) - risk of steroid-induced glaucoma and cataracts
- Open wounds, ulcers, or burns - systemic absorption risk
- Do not use as a skin-lightening cream (common misuse in India)
Precautions
| Patient Group | Guidance |
|---|
| Pregnancy | Avoid on large areas for prolonged periods. Consult doctor. Category C risk. |
| Breastfeeding | Do not apply on the breast or near it. Use minimum amount. |
| Children | Use with extreme caution. Children have higher surface area-to-body weight ratio → greater systemic absorption. Do not use in infants. |
| Elderly | Higher skin atrophy risk. Use minimum effective amount for shortest duration. |
| Face/skin folds | Absorption greatly enhanced. Avoid unless specifically directed. |
| Large BSA application | Risk of HPA axis suppression, Cushing syndrome. |
| Kidney disease | Caution - gentamicin may accumulate if absorbed. |
| Thyroid tests | Clioquinol can interfere with iodine-based thyroid tests. |
Drug Interactions
| Interacting Drug | Effect |
|---|
| Other topical steroids | Additive HPA axis suppression |
| Systemic corticosteroids | Combined systemic load - Cushing risk |
| Systemic aminoglycosides (IV Gentamicin) | Additive ototoxicity and nephrotoxicity if absorbed |
| Ketoconazole + systemic CYP3A4 substrates | Negligible with topical ketoconazole (minimal systemic absorption) |
| Immunosuppressants | Increased risk of opportunistic infection under the occlusion site |
Storage
- Store below 25-30°C (room temperature)
- Protect from direct sunlight and heat
- Do not freeze
- Keep tube tightly closed
- Keep out of reach of children
Key Clinical Points
- Not for skin lightening - a very common misuse in India that leads to steroid-induced skin damage (atrophy, telangiectasia, fungal overgrowth, steroid dependence).
- Dual antifungal coverage (Ketoconazole + Tolnaftate) ensures coverage for both azole-sensitive fungi AND dermatophytes; Tolnaftate fills the gap where azoles may be less effective.
- Clioquinol complements Gentamicin by covering organisms Gentamicin misses (some gram-positives, anaerobes, Candida), making this truly broad-spectrum.
- Limit to 2-4 weeks - the clobetasol 0.05% component is a Class I super-potent steroid and carries significant risks with prolonged use.
- Resistance concern - overuse of this combination (especially the antibiotic gentamicin) contributes to antimicrobial resistance.
- Do not apply on face, axillae, groin routinely - enhanced absorption in these areas multiplies adverse effects.
- Confirm the diagnosis first - if the underlying condition is viral (herpes) or purely inflammatory without infection, this combination is inappropriate and may worsen the condition.
Sources: Fitzpatrick's Dermatology (Vol. 1-2), Katzung's Basic & Clinical Pharmacology 16e, Andrews' Diseases of the Skin, Goodman & Gilman's Pharmacological Basis of Therapeutics, Jawetz Microbiology 28e, 1mg/Truemeds verified drug databases.